(Sharecast News) - AOTI said in an update on Monday that it expects to report full-year 2025 revenue and adjusted EBITDA margin in line with market consensus, despite reimbursement headwinds in the US healthcare market, as it positioned for renewed growth in 2026.
The AIM-traded medical technology group said it expected...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE